Miracalus Pharma Private Limited, a active private limited company, was established on 22 May 2007 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230MH2007PTC171043. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.17 M.
It upholds a compliant status. Employing 21 professional, Its leadership includes Manish Babulal Jain (Director), Mohan Babulal Jain (Director), Aarya Mohan Jain (Additional Director). Past directors included Kamala Babulal Jain, Manish Babulal Jain, Babulal Kesharimal Jain. It holds no open charges and ₹10.00 Cr settled loans. Its latest AGM occurred on 20 September 2024, with the balance sheet filed on 31 March 2024. It is based at 304, Town Centre, Near Mittal Estate, Andheri-Kurla Road, Andheri (E), Mumbai, Maharashtra, 400059.
U24230MH2007PTC171043
171043
22 May 2007
₹0.50 M
₹0.17 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Miracalus Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manish Babulal Jain | Director | 11 Sep 2018 | Current |
| Mohan Babulal Jain | Director | 22 May 2007 | Current |
| Aarya Mohan Jain | Additional Director | 13 Mar 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 Aug 2023 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Director | 08 Jan 2021 | Past |
| Pramod Abcsdd | Director | 01 Apr 2017 | Past |
| Pramod Abcsdd | Director | 01 Jun 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Miracalus Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 34.95% decrease. The company also saw a substantial fall in profitability, with a 1290.28% decrease in profit. The company's net worth observed a substantial decline by a decrease of 15.11%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Miracalus Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹100,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Oct 2015 | Bank Of Baroda | ₹5.50 Cr | Satisfied |
| 25 Jul 2011 | Icici Bank Limited | ₹4.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Miracalus Pharma has a workforce of 21 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Miracalus Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Miracalus Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Aarya Mohan Jain was appointed as a Additional Director was appointed as a Additional Director on 13 Mar 2025 & has been associated with this company since 8 months 13 days . was documented.
Progress on Miracalus Pharma Private Limited last Annual general meeting of members was held on 20 Sep 2024 as per latest MCA records. was documented.
Miracalus Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Manish Babulal Jain was appointed as a Director was appointed as a Director on 11 Sep 2018 & has been associated with this company since 7 years 2 months . was recorded as a recent event.
A charge registered on 26 Oct 2015 via Charge ID 10614303 with Bank Of Baroda was fully satisfied on 17 Nov 2017. was recorded as a recent event.
A charge registered on 25 Jul 2011 via Charge ID 10298799 with Icici Bank Limited was fully satisfied on 02 Nov 2015. was recorded as a recent event.
The CIN of Miracalus Pharma Private Limited is U24230MH2007PTC171043.
Miracalus Pharma Private Limited is headquartered at 304, Town Centre, Near Mittal Estate, Andheri-Kurla Road, Andheri (E), Mumbai, Maharashtra, 400059.
Miracalus Pharma Private Limited was incorporated on 22 May 2007.
The current directors of Miracalus Pharma Private Limited are
The primary industry of Miracalus Pharma Private Limited is Trade.
Miracalus Pharma Private Limited is unlisted.
The authorized capital of Miracalus Pharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.17 M.
The compliance status of Miracalus Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX